By Foo Yun Chee
BRUSSELS, June 26 (Reuters) - France-based Cooper Consumer Health on Wednesday secured EU antitrust approval to buy U.S. drugmaker Viatris' European over-the-counter drug business after agreeing to sell its rights and 비아그라약효 interests in an infant laxative medicine and earwax removal product.
The companies announced the $3.6 billion deal last October, with Viatris selling some of its businesses to focus on ophthalmology, gastroenterology and dermatology.
The European Commission, 비아88 which acts as the EU competition enforcer, 비아88 said Cooper's concessions came after it voiced concerns about the high combined market shares as a result of the deal and 비아그라 부작용 also insufficient competitive pressure from rivals.